- アズワンのAXELショップ
- 試薬
- 特定メーカー試薬
- US Biological(antibodypab)
-
84-2013-75 [取扱停止]EPS8L3, NT (Epidermal Growth Factor Receptor Kinase Substrate 8-like Protein 3, Epidermal Growth Factor Receptor Pathway Substrate 8-related Protein 3, EPS8-like Protein 3, EPS8R3) (PE) 200ul E3439-42-PE
84-2013-75 [取扱停止]EPS8L3, NT (Epidermal Growth Factor Receptor Kinase Substrate 8-like Protein 3, Epidermal Growth Factor Receptor Pathway Substrate 8-related Protein 3, EPS8-like Protein 3, EPS8R3) (PE) 200ul E3439-42-PE
特徴
- EPS8L3 is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor.
- The function of this protein is unknown.
- Applications:Suitable for use in FLISA and Western Blot.
- Other applications not tested.
- Recommended Dilution:FLISA: 1:1,000Western Blot: 1:100-1:500Optimal dilutions to be determined by the researcher.
- Storage and Stability:Store product at 4°C in the dark.
- DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- Caution: PE conjugates are sensitive to light.
- For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Note: Applications are based on unconjugated antibody.
仕様
- Size:200ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with R-Phycoerythrin (PE).
- Specificity:Recognizes human EPS8L3.
- Isotype:IgG
- Calc Applications Abbrev:FLISA WB
- Calc Crossreactivity:Hu
- Immunogen:Synthetic peptide selected from the N-terminal region of human EPS8L3 (KLH).
- Shelf Life:6months
- Swiss Prot Number:Q8TE67
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]